Detalhe da pesquisa
1.
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Br J Haematol
; 190(5): 736-740, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236950
2.
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial.
J Clin Oncol
; 42(2): 180-191, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788412
3.
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial.
Lancet Haematol
; 3(12): e581-e591, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27890073